News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Universal Ibogaine appoints Nick Karos to the Board of Directors
Universal Ibogaine
Psyched Wellness Provides Corporate Update
Psyched Wellness
Core One Labs' Scientists Successfully Complete Breakthrough First Step in Producing API-Grade DMT
Core One Labs Inc.
Psychedelic Weekly Headlines | September 2nd
Pharmala Biotech Holdings
Cybin Inc.
Lobe Sciences
Optimi Health
Filament Health
Red Light Holland Announces Live Investor Q&A Session at 2:00 PM (EST) on Thursday, September 8, 2022
Red Light Holland
Mydecine Innovations Group Signs a Letter of Intent to Sell its Wholly-Owned Subsidiary, Mindleap Health Inc.
Mydecine Innovations Group
Filament Health And Atma Journey Centers Announce 14 Subjects Dosed In Health Canada-approved Psilocybin Clinical Trial
Filament Health
Core One Rolls Out Commercial Sales Strategy for its Revolutionary API Grade Biosynthetic Psilocybin
Core One Labs Inc.
Algernon Pharmaceuticals Reports Positive Results from Full Data Set of its Phase 2 Study of Ifenprodil for IPF and Chronic Cough
Algernon Pharmaceuticals
Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome
Bright Minds
PharmAla Biotech to supply University of Sydney Clinical Trial with LaNeo™ MDMA
Pharmala Biotech Holdings
Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders
Reunion Neuroscience
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.